Close Menu

NEW YORK (GenomeWeb) – Invitae reported after the close of the market Tuesday that its fourth quarter 2018 revenues increased 78 percent from the prior year.

For the three months ended Dec. 31, 2018, Invitae reported $45.4 million in revenues compared to $25.4 million in Q4 2017, beating the consensus Wall Street estimate of $40.8 million. Invitae reported testing revenue of $44.5 million for the quarter, which includes $1.9 million in payments from Medicare for Lynch syndrome analysis, as well as $810,000 in other revenue.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.